[Form 4] Arvinas, Inc Insider Trading Activity

Rhea-AI Filing Summary

On 06/30/2025, Arvinas, Inc. (ARVN) filed a Form 4 disclosing equity awards granted to director Sunil Agarwal on 06/25/2025. The filing reports two separate awards:

• 16,025 Restricted Stock Units (RSUs) acquired at no cost. Each RSU converts into one common share once vested. Vesting occurs in full on the earlier of 25 Jun 2026 or the first board meeting following the next annual shareholder meeting, contingent on the director’s continued service.
• 23,105 stock options carrying a $7.80 exercise price and expiring 24 Jun 2035. These options follow the same one-year cliff vesting schedule as the RSUs.

No shares were sold or disposed of in this transaction. Following the grant, Agarwal’s direct beneficial ownership stands at 30,166 common shares, in addition to the newly issued 23,105 options.

The transaction was coded “A” (acquisition) and carried out for no cash consideration, indicating a routine director compensation grant rather than open-market activity.

Insights

Corporate Governance Expert

Routine director equity grant; neutral market impact.

Arvinas’ Form 4 reflects a standard annual compensation package: 16,025 RSUs and 23,105 ten-year options for director Sunil Agarwal. The awards align incentives but involve no cash outlay or open-market buying, so they provide limited insight into the director’s view on valuation. The total shares involved are immaterial relative to Arvinas’ outstanding stock, and the one-year cliff vesting encourages service continuity through the next shareholder meeting. Overall, this is a customary governance action with negligible effect on ownership concentration or control.

Portfolio Manager

No insider selling; ownership rises modestly.

The disclosure shows an increase in Agarwal’s stake to 30,166 shares plus 23,105 options, with no shares sold. While the absence of selling is mildly reassuring, the equity was granted—not purchased—so it does not reflect incremental capital commitment. The $7.80 exercise price is well below prevailing market levels, giving in-the-money optionality but little new information for valuation analysis. I classify this event as routine and not materially impactful to the ARVN investment thesis.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

AGARWAL SUNIL

(Last) (First) (Middle)

C/O ARVINAS, INC., 5 SCIENCE PARK

395 WINCHESTER AVENUE

(Street)

NEW HAVEN CT 06511

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ARVINAS, INC. [ ARVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/25/2025		A		16,025(1)	A	$0	30,166	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$7.8	06/25/2025		A		23,105		(2)	06/24/2035	Common Stock	23,105	$0	23,105	D

Explanation of Responses:

1. The restricted stock units (each, an "RSU") were granted by the Issuer on June 25, 2025 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date.

2. This option award was granted on June 25, 2025. The shares underlying the award shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date.

Remarks:

	/s/ Jared Freedberg, as attorney-in-fact for Sunil Agarwal	06/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many ARVN shares did director Sunil Agarwal acquire in the Form 4?

16,025 restricted stock units (RSUs) were granted to Sunil Agarwal on 06/25/2025, each convertible into one common share.

What derivative securities were issued to Sunil Agarwal by Arvinas?

He received 23,105 stock options with a $7.80 exercise price, expiring on 06/24/2035.

When do the RSUs and options granted to Sunil Agarwal vest?

Both awards vest in full on the earlier of 25 Jun 2026 or the first board meeting after the next annual shareholder meeting, subject to continued service.

What is Sunil Agarwal’s total direct ownership after the reported transaction?

Following the grant, he directly owns 30,166 ARVN common shares plus the newly granted 23,105 options.

Did the Form 4 report any insider sales of ARVN stock?

No. All reported transactions were coded "A" for acquisition; there were no disposals or sales.